Overview
- A peer‑reviewed study from Rice University in the International Journal of Obesity finds people judge GLP‑1 users more negatively than those who lose weight through diet and exercise, and even more harshly than people who do not lose weight.
- The same study reports strong social penalties for weight regain after stopping GLP‑1s or after dieting, which researchers warn can affect mental health and care‑seeking.
- WRAL reports a Raleigh restaurant, Coquette, has cut portion sizes, shifted dishes toward protein, and lowered prices, as the owner plans a GLP‑1‑focused menu and national chains adjust offerings.
- KFF estimates roughly one in eight U.S. adults now take a GLP‑1 drug, and a Duke clinician says about three‑quarters of his new patients ask for these medications.
- Doctors explain the drugs curb appetite and cravings rather than boost metabolism, and they caution that long‑term effects remain unclear and weight often returns when treatment stops.